Products

The Pharmstandard group of companies manufactures more than 250 pharmaceutical products, the Company's portfolio is diversified and is represented in 108 anatomical therapeutic chemical groups accounting for 37% of their total number (ATC groups of the third level). The anatomical therapeutic chemical groups in which the Company’s pharmaceutical products are represented, account for 74 % of the total pharmaceutical market in value terms and 88% of the market in volume terms.

The TOP-10 Pharmstandard products occupy key positions in their respective groups: Arbidol® and Amixin® (J05B Antivirals, excluding anti-HIV products), Pentalgin® (N02B Non-narcotics and anti-pyretics), Complivit® (A11A Multivitamins with minerals), Terpincod® and Codelac® (R05D Antitussives), Flucostat® (J02A Systemic agents for fungal infections), Afobazol® (N05C Tranquillisers) and Corvalol (N05B Hypnotics/Sedatives), Phosphogliv® (A05B Hepatic protectors, lipotropics).

In 2011, two brands, Arbidol® and Pentalgin® were in the TOP-15 brands as per volume of sales in the whole of the pharmaceutical market in Russia, and in TOP-10 in the retail segment.

Nine of the Company’s brands were included in the TOP-25 for domestically manufactured products: Arbidol®, Pentalgin®, Complivit®, Flucostat®, Codelac®, Amixin®, Phosphogliv®, Afobazol® and Terpincod®.

The following segments of the pharmaceutical market are of prime importance for Pharmstandard:

  • J05 Antivirals for systemic use
  • N02 Analgesics
  • R05 Cough and cold preparations
  • A11 Vitamins
  • N05 Psycholeptics
  • J02 Systemic agents for fungal infections
  • A05 Cholagogues and hepatic protectors
  • A07 Antidiarrhoels, oral electrolyte repacers and intestinal anti-inflammatories.

In 2011, just like in 2010, growth continued in all segments, except for Systemic Antivirals, which was due to the absence of flu and cold pandemic during the final months of 2011.

This table shows sales results for TOP-10 pharmaceutical products of the Company in 2011:



2011

2010

Volume 11/10

Sales 11/10

BRAND

Volume (mln packs)

Sales (mln RUR)

% of total sales

Volume (mln packs)

Sales (mln RUR)

% of total sales

Change

%

Change

%

1

Arbidol

25.839

4011

20.8%

42.640

5589

29.6%

-16.802

-39.4%

-1,579

-28.2%

2

Pentalgin

41.915

2375

12.3%

38.124

1988

10.5%

3.791

9.9%

387

19.4%

3

Complivit

16.608

1458

7.6%

14.903

1228

6.5%

1.705

11.4%

230

18.7%

4

Terpincod

7.782

1207

6.3%

7.470

1047

5.5%

0.312

4.2%

160

15.3%

5

Phosphogliv

2.487

925

4.8%

2.083

699

3.7%

0.404

19.4%

226

32.3%

6

Codelac

9.858

872

4.5%

8.317

692

3.7%

1.542

18.5%

181

26.1%

7

Afobazol

4.991

772

4.0%

4.093

607

3.2%

0.898

21.9%

165

27.1%

8

Flucostat

5.770

717

3.7%

5.609

653

3.5%

0.161

2.9%

64

9.8%

9

Amixin

1.289

570

3.0%

1.367

564

3.0%

-0.077

-5.7%

6

1.0%

10

Biosulin

0.794

409

2.1%

0.731

361

1.9%

0.064

8.7%

48

13.3%

TOP 10 total

117.333

13,316

69.2%

125.336

13,429

71.1%

-8.003

-6.4%

-113

-0.8%

Other brands

548.020

5,920

30.8%

582.266

5,446

28.9%

-34.246

-5.9%

474

8.7%

TOTAL SALES

665.353

19,237

100.0%

707.602

18,875

100.0%

-42.249

-6.0%

362

1.9%

 

* all Flucostat forsm (tablets and injections)

 

** all Amixin forms (№125 и №60)

Products






Menu
Company profile Mission Strategy Achievments Corporate Governance Shareholder structure Social Policy Products    Over The Counter (OTC)    Prescription Pharmaceuticals (RX)    Vital and Essential Pharmaceuticals (VEP)    Third Parties Pharmaceuticals (TPP)    Research & Development Facilities Corporate film Reorganization Company presentations Press releases Financial reports Annual reports Investor tools Investor calendar Analyst Coverage
Corporate film
Markets information WAP version
Delayed according to exchanges regulations. RUSTOCKS.com
Company profile Company presentations Press releases Financial reports Annual reports Investor tools Investor calendar Analyst Coverage
© 2007–2013 All rights reserved.
Terms of use www.pharmstd.com